Smart Blood Analytics Swiss has obtained certification under the European Medical Device Regulation (EU-MDR) for its VIRUS versus BACTERIA Clinical Decision Support Software, marking a significant advancement in the fight against antimicrobial resistance (AMR), a growing global health concern.
READ: Navigating Amsterdam’s Waterways: A Canal Cruise Experience
Swiss
AMR is fueled by the improper use of antibiotics, posing serious threats to public health and imposing substantial financial burdens on healthcare systems. The VIRUS versus BACTERIA software aims to tackle this issue by accurately distinguishing between viral and bacterial infections, aiding physicians in prescribing the most suitable treatments.
By utilizing 17 routine blood parameters, along with biological sex and age, the software effectively discerns between infections. Its efficacy and precision were recently highlighted in a publication in the Heliyon journal.
With routine blood testing widely available, VIRUS versus BACTERIA stands to enhance doctors’ diagnostic capabilities globally, especially in situations where other blood markers offer limited diagnostic value.
Dr. Marko Notar, CEO of Smart Blood Analytics Swiss, emphasized, “This accomplishment underscores our dedication to advancing healthcare through innovation. By furnishing clinicians with a precise tool to differentiate between viral and bacterial infections, we aim to equip doctors with crucial information to aid in their decision-making regarding antibiotic prescriptions, thereby promoting more effective healthcare practices.”
The inspiration for VIRUS versus BACTERIA stemmed from the 2022 G20 Bali summit, which issued a clarion call to address AMR, highlighting the urgent need for innovative solutions to combat this silent pandemic.
The EU-MDR certification process is stringent, ensuring that medical devices meet stringent standards of safety, quality, and compliance with EU regulations. With this certification, VIRUS versus BACTERIA is poised to become a valuable tool for healthcare professionals worldwide.
Featuring a user-friendly interface, the software empowers practitioners in their endeavors to judiciously and effectively utilize antibiotics in the battle against antimicrobial resistance.
